Table 5.
Change over baseline |
95% CI |
|||||
---|---|---|---|---|---|---|
Treatment | DV | M | SD | Lower | Upper | Significant |
STRUC | VO2 | −0.2 | 11.8 | −106.3 | 105.8 | 0.981 |
MAP | −2.5 | 8.3 | −4.1 | −0.8 | 0.004* | |
TC | −0.1 | 0.5 | −0.1 | 0.1 | 0.402 | |
FREE | VO2 | 6.7 | 4.2 | −30.7 | 44.2 | 0.262 |
MAP | −1.0 | 6.3 | −2.3 | 0.2 | 0.112 | |
TC | +0.1 | 0.5 | −0.1 | 0.1 | 0.995 | |
PAC | VO2 | −6.0 | 5.3 | −19.1 | 7.1 | 0.188 |
MAP | −1.2 | 6.5 | −2.8 | 0.3 | 0.125 | |
TC | +0.1 | 0.5 | −0.1 | 0.1 | 0.698 | |
CONT | VO2 | 1.8 | 3.1 | −26.1 | 29.7 | 0.563 |
MAP | −1.3 | 7.9 | −3.2 | 0.6 | 0.167 | |
TC | +0.2 | 0.5 | 0.1 | 0.3 | 0.005* |
*Statistically significant difference between treatment groups where α was set at 0.05.
CONT, control condition; FREE, unstructured gym exercise; MAP, mean arterial pressure; PAC, physical activity counseling; STRUC, structured gym exercise programme; TC, total cholesterol.